Deletions of the 6q16.3 region of their tumor-suppressor Glutamate Ionotropic Receptor Kainate Type Subunit 2 (GRIK2) gene in osteosarcomas have been shown to interfere with SETDB1 binding since this deleted region contains a SETDB1 binding site [122]. This evidence concerns the gene SETDB1 and neoplasm.